Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcbest (ARCB) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Arcbest (ARCB) over the last 17 years, with Q3 2025 value amounting to $120.6 million.

  • Arcbest's Cash & Equivalents fell 1984.37% to $120.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $120.6 million, marking a year-over-year decrease of 1984.37%. This contributed to the annual value of $127.4 million for FY2024, which is 5139.92% down from last year.
  • Per Arcbest's latest filing, its Cash & Equivalents stood at $120.6 million for Q3 2025, which was down 1984.37% from $114.9 million recorded in Q2 2025.
  • Arcbest's Cash & Equivalents' 5-year high stood at $408.2 million during Q3 2021, with a 5-year trough of $64.1 million in Q1 2022.
  • For the 5-year period, Arcbest's Cash & Equivalents averaged around $186.0 million, with its median value being $158.3 million (2022).
  • As far as peak fluctuations go, Arcbest's Cash & Equivalents tumbled by 7873.99% in 2022, and later soared by 21715.07% in 2023.
  • Quarter analysis of 5 years shows Arcbest's Cash & Equivalents stood at $76.6 million in 2021, then surged by 106.56% to $158.3 million in 2022, then soared by 65.69% to $262.2 million in 2023, then plummeted by 51.4% to $127.4 million in 2024, then decreased by 5.37% to $120.6 million in 2025.
  • Its Cash & Equivalents was $120.6 million in Q3 2025, compared to $114.9 million in Q2 2025 and $74.1 million in Q1 2025.